Rochelle Bagatell, M.D.

faculty photo
Associate Professor of Pediatrics at the Children's Hospital of Philadelphia
Department: Pediatrics

Contact information
The Children's Hospital of Philadelphia
Division of Oncology, 4022 CTRB
3501 Civic Center Boulevard
Philadelphia, PA 19104
Office: 267-426-9737
BA (History)
Brown University, 1987.
University of Arizona, 1993.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Fitzgerald JC, Li Y, Fisher BT, Huang YS, Miller TP, Bagatell R, Seif AE, Aplenc R, Thomas NJ.: Hospital Variation in Intensive Care Resource Utilization and Mortality in Newly Diagnosed Pediatric Leukemia. Pediatric Critical Care Medicine March 2018.

Fox E, Levin K, Zhu Y, Segers B, Balamuth N, Womer R, Bagatell R, Balis F. : Pantoprazole, an Inhibitor of the Organic Cation Transporter 2, Does Not Ameliorate Cisplatin-Related Ototoxicity or Nephrotoxicity in Children and Adolescents with Newly Diagnosed Osteosarcoma Treated with Methotrexate, Doxorubicin, and Cisplatin. The Oncologist Feb 2018.

Vogel J, Both S, Kirk M, Chao HH, Bagatell R, Li Y, Womer R, Balamuth N, Reilly A, Kurtz G, Lustig R, Tochner Z, Hill-Kayser C.: Proton Therapy for Pediatric Head and Neck Malignancies. Pediatric Blood & Cancer 65(2), Feb 2018.

Setty Bhuvana A, Stanek Joseph R, Mascarenhas Leo, Miller Alexandra, Bagatell Rochelle, Okcu Fatih, Nicholls Lauren, Lysecki David, Gupta Abha A: Vincristine, Irinotecan, and Temozolomide in Children and Adolescents with Relapsed Rhabdomyosarcoma. Pediatric Blood & Cancer 65(1), Jan 2018.

London WB, Bagatell R, Weigel BJ, Fox E, Guo D, Van Ryn C, Naranjo A, Park J R: Historical Time to Disease Progression and Progression-Free Survival in Patients with Recurrent/Refractory Neuroblastoma Treated in the Modern Era on Children's Oncology Group Early-Phase Trials. Cancer 123(24): 4914-4923, Dec 2017.

Campbell Kevin, Gastier-Foster Julie M, Mann Meegan, Naranjo Arlene H, Van Ryn Collin, Bagatell Rochelle, Matthay Katherine K, London Wendy B, Irwin Meredith S, Shimada Hiroyuki, Granger M Meaghan, Hogarty Michael D, Park Julie R, DuBois Steven G: Association of MYCN Copy Number with Clinical Features, Tumor Biology, and Outcomes in Neuroblastoma: A Report from the Children's Oncology Group. Cancer 123(21): 4224-4235, Nov 2017.

Mody Rajen, Naranjo Arlene, Van Ryn Collin, Yu Alice L, London Wendy B, Shulkin Barry L, Parisi Marguerite T, Servaes Sabah-E-Noor, Diccianni Mitchell B, Sondel Paul M, Bender Julia G, Maris John M, Park Julie R, Bagatell Rochelle: Irinotecan-Temozolomide with Temsirolimus or Dinutuximab in Children with Refractory or Relapsed Neuroblastoma (COG ANBL1221): an Open-label, Randomised, Phase 2 Trial. The Lancet Oncology 18(7): 946-957, July 2017.

Park Julie R, Bagatell Rochelle, Cohn Susan L, Pearson Andrew D, Villablanca Judith G, Berthold Frank, Burchill Susan, Boubaker Ariane, McHugh Kieran, Nuchtern Jed G, London Wendy B, Seibel Nita L, Lindwasser O Wolf, Maris John M, Brock Penelope, Schleiermacher Gudrun, Ladenstein Ruth, Matthay Katherine K, Valteau-Couanet Dominique: Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 35(22): 2580-2587, May 2017.

Miller Tamara P, Li Yimei, Getz Kelly D, Dudley Jesse, Burrows Evanette, Pennington Jeffrey, Ibrahimova Azada, Fisher Brian T, Bagatell Rochelle, Seif Alix E, Grundmeier Robert, Aplenc Richard: Using Electronic Medical Record Data to Report Laboratory Adverse Events. British Journal of Haematology 177(2): 283-286, Apr 2017.

Bagatell Rochelle, Grupp Stephan A: Refining Megatherapy, Improving Outcome in Neuroblastoma. The Lancet Oncology 18(4): 423-424, Apr 2017.

back to top
Last updated: 04/19/2018
The Trustees of the University of Pennsylvania